Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,208.80
Bid: 1,210.40
Ask: 1,211.00
Change: 8.20 (0.68%)
Spread: 0.60 (0.05%)
Open: 1,201.00
High: 1,221.40
Low: 1,198.60
Yest. Close: 1,200.60
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Broker tips: Imperial Tobacco, Legal & General, GlaxoSmithKline...

Goldman Sachs has removed Imperial Tobacco from its 'Conviction List', saying it sees less potential upside from current levels. Nevertheless, the bank kept its 'buy' recommendation and 2,780p target price. Since being added to the Conviction List at the end of January, the stock has gained nearly

17 Apr 14 13:13

GSK guidance looking 'increasingly challenging', says UBS

UBS has reduced its target price for GlaxoSmithKline (GSK) from 1,650p to 1,500p, saying that forecasts for earnings growth may continue to prove elusive for the pharmaceutical group. "The prospect of earnings per share (EPS) growth has been delayed year after year at GSK. Consensus - as every year

17 Apr 14 11:50

UK MIDDAY BRIEFING: Hester Making Quick Work Of RSA Revamp

LONDON (Alliance News) - <strong>RSA Insurance Group</strong> Chief Executive Stephen Hester Thursday went a long way to meeting his asset disposal target, selling the insurer's Polish and Baltic operations as part of its efforts to shore up its balance sheet in the wake of big losses in Irela

17 Apr 14 11:47

GSK, facing bribery claims, battles to build new sales model

* Drugmaker to hire 10-20 pct more doctors in-house * Follows move to stop paying outsiders to promote drugs * GSK hopes for long-term competitive advantage with revamp * Short-term challenge to maintain effective promotion By Ben Hirschler LONDON, April 17 (Reuters)

17 Apr 14 10:39

Glaxo Confirms Investigations In Jordan, Lebanon Operations

LONDON (Alliance News) - GlaxoSmithKline PLC confirmed that it was investigating allegations of misconduct in its Jordan and Lebanon operations in a statement Wednesday, the latest in a series of mounting investigations across its business. The pharmaceutical giant is currently investigatin

17 Apr 14 10:03

UK BROKER RATINGS: Berenberg Raises St James's Place Price Target

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />JEFFERIES CUTS WILLIAM HILL TO 'HOLD' ('BUY') <br />----------<br />GOLDMAN CUTS IMPERIAL TOBACCO TO 'BUY' ('CONVICTION BUY LI

17 Apr 14 09:04

Galapagos, GSK successfully conclude phase 2a study of skin disease drug

BRUSSELS, April 17 (Reuters) - Belgian biotech group Galapagos NV on Thursday said it has successfully concluded the phase 2a study of a skin disease drug it is developing with Britain's GlaxoSmithKline PLC. Galapagos tested drug GSK2586184 on 66 patients with chronic psoriasis and observed

17 Apr 14 05:40

UPDATE 1-GSK says investigating claims of bribery in Jordan, Lebanon

* Doctors allegedly offered free samples, travel benefits * Follows earlier claims of bribes in China, Poland, Iraq (Adds details on allegations, further GSK comment) LONDON, April 16 (Reuters) - GlaxoSmithKline, Britain's biggest drugmaker, said on Wednesday it was investigating al

16 Apr 14 16:24

GSK says investigating claims of bribery in Jordan, Lebanon

LONDON, April 16 (Reuters) - Drugmaker GlaxoSmithKline said on Wednesday it was investigating allegations of bribery involving some of its staff in Jordan and Lebanon, following earlier claims of corruption in China, Iraq and Poland. "GSK can confirm we are investigating allegations regard

16 Apr 14 15:16

Glaxo Receives US Approval For Type 2 Diabetes Treatment

LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said it has received US approval for once-weekly type 2 diabetes treatment Tanzeum or albiglutide, with the company now anticipating the US launch of the treatment in the third-quarter of 2014. In a statement, the pharmaceutical giant sai

15 Apr 14 17:17

UPDATE 1-FDA approves GSK's Tanzeum to treat type 2 diabetes

(Adds details, background, stock movement) April 15 (Reuters) - The U.S. Food and Drug Administration approved GlaxoSmithKline Plc's Tanzeum injection for treating adults with type 2 diabetes, in combination with diet and exercise. Tanzeum will carry a warning on its label that tumors

15 Apr 14 15:45

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares, ADSs

LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives, including Chief Executive Andrew Witty, acquired shares and American Depositary Shares under the 2009 deferred annual bonus plan at a price of 1581.50 pence per share and USD53.42 per ADS each following a dividend

15 Apr 14 15:08

FDA approves GSK's Tanzeum to treat type 2 diabetes

April 15 (Reuters) - The U.S. Food and Drug Administration approved GlaxoSmithKline Plc's Tanzeum injection for treating adults with type 2 diabetes, in combination with diet and exercise. Tanzeum will carry a warning on its label that tumors of the thyroid gland were observed in rodent stu

15 Apr 14 14:35

Tuesday tips round-up: RWS Holdings, GlaxoSmithKline

As Chinese companies increasingly look to rigorously protect their intellectual property claims in the western world companies such as RWS Holdings will benefit. The firm obtains 70 per cent of its sales from translation services for corporates that allow them to protect their copyrights across a ra

15 Apr 14 07:22

U.S. healthcare usage and spending resumes rise in 2013 -report

By Bill Berkrot April 15 (Reuters) - Americans used more health services and spent more on prescription drugs in 2013, reversing a recent trend, though greater use of cheaper generic drugs helped control spending, according to a report issued on Tuesday by a leading healthcare information c

15 Apr 14 04:01

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.